While Generative AI is creating a buzz across industries and remains in the early stages of the hype cycle, AI in radiology is no longer just a vision for the future.
mediaire’s proven AI value is already happening in over 350 hospitals and clinics across Europe, where the German radiology innovator’s AI portfolio is transforming how radiologists work. With this success, mediaire has secured a €12 million European-led financing round, headed by lead investor LBO France with participation from IBB Ventures and the Swiss family office Wille Finance. It highlights the importance of demonstrating that AI technology truly works in clinical practice. The oversubscribed financing round included continued support from existing investors HTGF, LIFTT, and Gateway Ventures.
By seamlessly integrating AI into daily diagnostics, mediaire is lifting the burden of routine analysis off the shoulders of radiologists, reducing medical workload, and improving patient outcomes. Thanks to the recent investment mediaire is set to expand its AI portfolio beyond brain, prostate, and knee diagnostics in magnetic resonance imaging (MRI). This next wave of innovation will tackle even more AI solutions, bringing AI-driven accuracy and efficiency to doctors globally. The funding marks a new phase in the company’s growth.
From left to right: Barbara von Horstig, Hemmelrath Law – Christian Seegers, IBB Ventures – Matthes Seeling, LBO France – Matthias Hofreiter, Gateway Ventures – Dr. Andreas Lemke, mediaire – Dr. Jörg Döpfert, mediaire – Franck Noiret, LBO France – Max Rüther, RSR Rüping Schroeder Rechtsanwälte for Wille Finance – Sebastian Burian, Representative of a private investor consortium – Teresa De Nadai, LIFTT
“Our AI solutions are not a futuristic dream. We have already created a reality that is helping doctors make better decisions and giving patients faster answers,” says Dr. Andreas Lemke, CEO, and co-founder of mediaire. “We are seeing the impact on thousands of radiologists every day in hundreds of hospitals and radiology practices across Europe that are utilizing our AI solutions. With this investment, we will be able to scale these benefits to even more healthcare providers.”
“We believe in the power of technology to improve lives,” said Matthes Seeling, LBO France’s Investment Director. “mediaire’s focus aligns perfectly with our firm belief in the transformative power of healthcare technology to the benefit of all professionals and patients. The dedicated team meets a crucial need in the healthcare sector considering the increasing global demand for fast, accurate and affordable diagnostics. With this investment, we will actively sustain mediaire’s growth to achieve its ambitious objectives and consolidate its position as a leader in radiology AI in Europe.”
Integral to mediaire’s success story are partnerships with renowned university hospitals and industry leaders such as Bayer/Calantic, Sectra, deepc, as well as radiology chains like Med360, Evidia, Starvision, and RIMED/UNILABS.
